Functional implications of CPVT1-associated RyR2 mutations in human cardiomyocytes

人类心肌细胞中 CPVT1 相关 RyR2 突变的功能意义

基本信息

批准号：
10298481
负责人：
MARTIN MORAD
金额：
$ 51.83万
依托单位：
UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA
依托单位国家：
美国
项目类别：
财政年份：
2021
资助国家：
美国
起止时间：
2021-09-01 至 2025-07-31
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10298481
关键词：
Adrenergic Agents Adrenergic beta-Agonists Adult Affinity Amino Acids Arrhythmia Back Binding Binding Sites Biochemical Biological Assay CRISPR/Cas technology Caffeine Cardiac Cardiac Myocytes Cardiomyopathies Catecholaminergic Polymorphic Ventricular Tachycardia Cell model Cells Complement Computer Simulation Coupling Data Disease Dissociation Electrophysiology (science)Exhibits FKBP1B gene Functional disorder Genes Genetic Heart Heart Hypertrophy Heart failure Human Human Engineering Imaging Device Impairment Knock-in Link Maps Mediating Membrane Missense Mutation Modeling Molecular Mus Muscle Cells Mutagenesis Mutate Mutation Myocardial dysfunction Myocardium Pathology Pharmaceutical Preparations Pharmacology Phenotype Phosphoric Monoester Hydrolases Phosphotransferases Protein Kinase Proteins Recombinants Regulation Research Resolution RyR1 Ryanodine Ryanodine Receptor Calcium Release Channel Ryanodine Receptors Sarcoplasmic Reticulum Signal Pathway Signal Transduction Site Specificity Structural Models Structure Structure-Activity Relationship System Tacrolimus Binding Proteins Tail Testing Total Internal Reflection Fluorescent Transgenic Mice alpha helix base confocal imaging human stem cells in vivo induced pluripotent stem cell insight interdisciplinary approach loss of function loss of function mutation molecular imaging mouse model mutant novel novel strategies patch clamp public health relevance response skeletal

项目摘要

Project Summary/Abstract: Cardiac contractility is regulated by Ca2+ release form the sarcoplasmic reticulum through ryanodine receptor (RyR2), a protein with multiple regulatory domains for Ca2+, Mg2+, protein kinase, caffeine and FKBP12.6. Since a number of RyR2 missense mutations associate with lethal cardiomyopathies, a detailed understanding of regulatory mechanisms of RyR2 is essential for treatment of these pathologies. Two strategies of heterologous expression of recombinant RyR2 mutants in HEK293 cells and transgenic mouse models, have been used to study structure/function relationship of RyR2 and the functional consequences of disease-linked RyR2 mutations. Although these approaches have provided new insights into RyR2 regulatory mechanisms, they have inherent drawbacks of cells with non-cardiac genetic background and differences in human and mice hearts. We have therefore established an alternate research platform where RyR2 mutations are introduced in human induced pluripotent stem cells (hiPSCs)-derived cardiomyocytes (CMs) using CRISPR/Cas9 gene-editing. Mutant myocytes are then cultured in media that matures them structurally and functionally toward adult cardiomyocyte state. Using this human myocyte platform, we propose to examine molecular mechanisms underlying Ca2+, caffeine, and FKBP regulation of RyR2 associated with CPVT1 pathology. Specifically we aim: 1) To compare Ca2+-signaling consequences of domain specific CPVT1-associated RyR2 mutations expressed in “mature” hiPSC-CMs , rescue their phenotype by back-mutagenesis, and determine their drug specificity; 2) To characterize the functional consequence of mutating the RyR2 Ca2+ and caffeine binding sites, predicted from near atomic structure and determine their interaction; and 3) To characterize mechanisms underlying loss-of-function CPVT1-associated RyR2 mutations and identify the difference between Ca2+ leaky and non-leaky mutations. To accomplish these aims we propose to create multiple mutant lines of our more mature hiPSC-CMs carrying the different RyR2 mutations and examine their Ca2+ signaling aberrancies. Membrane currents and intracellular Ca2+ signals of wild type and mutant hiPSC- derived cardiomyocytes will be quantified in patch-clamped myocytes imaged by confocal/TIRF microscopy using genetically encoded Ca2+ probes targeted to various nodes of Ca2+ signaling pathway. We will also use [3H]ryanodine binding assay, to determine possible alterations in affinities of Ca2+, caffeine and accessory proteins. To assure the reliability of our hiPSC-platform, we will compare the Ca2+ signaling aberrancies of mutagenesis in hiPSC-CMs with in vivo knock-in of RyR2 mutations in mouse models. We hope that our novel approach will make it possible to systematically characterize the phenotype of the CPVT1 mutants, as well as non-CPVT1 mutants with implication to atomic structure of RyR2, in human myocardium, thus providing a novel and synergistic human platform for studies of RyR2 regulation.

项目摘要/摘要：心肌收缩力通过兰尼碱受体从肌浆网释放 Ca2+ 来调节 (RyR2)，一种具有 Ca2+、Mg2+、蛋白激酶、咖啡因和 FKBP12.6 多个调节域的蛋白质。许多 RyR2 错义突变与致命性心肌病相关，详细了解 RyR2 的调节机制对于治疗这些疾病至关重要。异源的两种策略。重组 RyR2 突变体在 HEK293 细胞和转基因小鼠模型中的表达已被用于研究 RyR2 的结构/功能关系以及疾病相关 RyR2 突变的功能后果。尽管这些方法为 RyR2 调控机制提供了新的见解，但它们具有固有的缺陷具有非心脏遗传背景的细胞的衰退以及人类和小鼠心脏的差异。因此建立了一个替代研究平台，将 RyR2 突变引入人类诱导的使用 CRISPR/Cas9 基因编辑技术对多能干细胞 (hiPSC) 衍生的心肌细胞 (CM) 进行研究。然后在培养基中培养心肌细胞，使它们在结构和功能上成熟为成年心肌细胞使用这个人类心肌细胞平台，我们建议检查潜在的分子机制 Ca2+，具体来说，我们的目标是：1) 比较 RyR2 的咖啡因和 FKBP 调节。域特异性 CPVT1 相关 RyR2 突变的 Ca2+ 信号后果 “成熟”的 hiPSC-CM，通过反向突变挽救其表型，并确定其药物特异性；2) 表征 RyR2 Ca2+ 和咖啡因突变的功能后果结合位点，从近原子结构预测并确定它们的相互作用；以及3) 表征功能丧失 CPVT1 相关 RyR2 突变的机制并确定为了实现这些目标，我们建议创建 Ca2+ 泄漏突变和非泄漏突变之间的差异。我们更成熟的 hiPSC-CM 的多个突变系携带不同的 RyR2 突变，并检查它们的野生型和突变型 hiPSC- 的膜电流和细胞内 Ca2+ 信号。衍生的心肌细胞将在通过共聚焦/TIRF 显微镜成像的膜片钳心肌细胞中进行定量我们还将使用针对 Ca2+ 信号通路各个节点的基因编码 Ca2+ 探针。 [3H]ryanodine 结合，以确定 Ca2+ 测定、咖啡因和辅助物的亲和力可能发生的变化为了确保我们的 hiPSC 平台的可靠性，我们将比较 Ca2+ 信号异常。我们希望我们的新研究能够在小鼠模型中通过体内敲入 RyR2 突变来实现 hiPSC-CM 的诱变。该方法将使系统地表征 CPVT1 突变体的表型成为可能，以及非 CPVT1 突变体与人心肌中 RyR2 的原子结构有关，从而提供了一种新的用于 RyR2 调控研究的协同人类平台。